Branden Wolner

Dr. Branden Wolner is an accomplished biotechnology and biopharma research leader with over 15 years of experience in innovation and management.

He has managed cross-functional projects with teams of up to 50 members, consistently delivering projects on time and under budget.

Dr. Wolner specializes in areas such as strain improvement, metabolic and genetic engineering technologies, high throughput screening, fermentation optimization, and gene expression.

His expertise extends to project management, personnel management, team building, and scientific communication.

With a PhD in Molecular Biology and Biochemistry from the University of California, Los Angeles, and a background in microbiology, he possesses a strong educational foundation.

Currently serving as the Founder and Principal Consultant at Recombinant DNA Technologies, Dr. Wolner has held various advisory and leadership roles in prominent organizations like Dow AgroSciences, SelectX Pharmaceuticals, and Intrexon Corporation.

His career spans roles ranging from Senior R&D Manager to Group Leader in areas like molecular biology, biochemistry, and metabolic engineering.

Dr. Wolner is known for his expertise in developing novel biocatalysts, leading process improvement efforts, and overseeing the creation of new products with significant revenue potential.

Based in San Diego, he offers consulting services in technology transfer, assay development, protein/enzyme engineering, and external collaboration.

Dr. Wolner's diverse skill set includes CMC/GMP manufacturing, leadership and mentoring, and fostering external partnerships to drive innovation and growth in the biotechnology industry.